Additionally, it was anticipated to a rise in diabetes cases globally due to modern lifestyles, obesity, physical inactivity, and population growth
A 3-week trial found methylene blue significantly improved the symptoms of patients with severe depression
Host microbiota constantly control maturation and function of microglia in the cns
Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products
Each additional treatment area increases surgical time, anesthesia, and facility costs